0
Nov 13 (Reuters) – GALDERMA GROUP AG: * MEXICO BECOMES FIRST MARKET WORLDWIDE TO RECEIVE APPROVAL FOR GALDERMA'S RESTYLANE® SHAYPE™ FOR BOTH CHIN AND ITS FIRST JAWLINE INDICATION * GRESTYLANE SHAYPE
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
